VIDEO: ECP for glaucoma has benefit over cataract surgery alone in early trial data

ByKin Sheng Lim, MD

ByAlex Young

Fact checked byChristine Klimanskis, ELS

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Kin Sheng Lim, MD, discusses a randomized controlled trial on endoscopic cyclophotocoagulation, or ECP, for primary open-angle glaucoma.

“The early data, 1-year washout, suggest that ECP does, in fact, provide additional benefit to cataract surgery alone in terms of IOP control and success rate at 1 year,” Lim said. “Obviously, the final analysis of the data is still to be done — we are awaiting the full statistical analysis — but so far, the data look very encouraging.”

Published by:

Sources/Disclosures

Collapse

Source:

Lim KS. Baseline characteristics of participants in the CONCEPT randomised controlled trial. Presented at: American Society of Cataract and Refractive Surgery meeting; April 5-8, 2024; Boston.

Disclosures: Lim reports that the study received unrestricted funding from BVI Medical.

American Society of Cataract and Refractive Surgery Meeting

Read more

VIDEO: ECP for glaucoma has benefit over cataract surgery alone in early trial data

Related Content